Scientific work

Uzm. Dr. Emin Oğuz

13 publications. The source of the information is stated next to each publication.

Back to profile

  1. 1. Oğuz E, Bektaş M. Characteristics of patients with Behçet disease from the Van province, eastern Turkey: Definition of disease clusters in a tertiary referral center. J Clin Rheumatol. 2023. doi:10.1097/RHU.0000000000001996

    Source: medipol.com.tr profile page

  2. 2. Oğuz E, et al. Characteristics and course of patients with AA amyloidosis: Single centre experience with 174 patients from Turkey. Rheumatology (Oxford). 2024;63(2):319-328. doi:10.1093/rheumatology/kead465

    Source: medipol.com.tr profile page

  3. 3. Oğuz E, et al. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: A controlled study. Clin Exp Rheumatol. 2024;42(2):358-366. doi:10.55563/clinexprheumatol/9u122p

    Source: medipol.com.tr profile page

  4. 4. Bektaş M, Özer MD, Oğuz E. The safety and efficacy of TNF inhibitors in patients with Behçet’s disease: Retrospective study from eastern Turkey. Clin Immunol. 2024;264:110239. doi:10.1016/j.clim.2024.110239

    Source: medipol.com.tr profile page

  5. 5. Oğuz E, Koca N, Bektaş M. Presence of myositis-specific autoantibodies may predict favorable outcomes to rituximab in patients with idiopathic inflammatory myositis: Retrospective observational study. Mod Rheumatol. 2025 (ahead of print). doi:10.1093/mr/roaf097

    Source: medipol.com.tr profile page

  6. 6. Oğuz E, et al. Chronic oxcarbazepine intoxication in a patient with primary antiphospholipid syndrome on maintenance haemodialysis. J Clin Pharm Ther. 2022;47(2):257-259. doi:10.1111/jcpt.13504

    Source: medipol.com.tr profile page

  7. 7. Oğuz E, et al. Activation-induced cytidine deaminase expression in patients with chronic myeloid leukemia Experimed. 2022;12(3):155-159

    Source: medipol.com.tr profile page

  8. 8. Oğuz E, et al. Üçüncü basamak bir hastanede takip edilen COVID-19 olgularında immünosüpresif tedavi uygulanan hastaların değerlendirilmesi. Klimik Dergisi. 2022

    Source: medipol.com.tr profile page

  9. ULUSLARARASI KONGRE SUNUMLARI (ACR)

    Source: medipol.com.tr profile page

  10. 9. Oğuz E, et al. Classification of idiopathic inflammatory myopathies: Assessment according to 2017 ACR/EULAR criteria. Arthritis Rheumatol. 2018;70(Suppl 9)

    Source: medipol.com.tr profile page

  11. 10. Oğuz E, et al. Favourable response to rituximab in IgG4-related disease: Long-term follow-up. Arthritis Rheumatol. 2018;70(Suppl 9)

    Source: medipol.com.tr profile page

  12. 11. Bektaş M, et al., Oğuz E. PET imaging in idiopathic inflammatory myositis: A case-control study. Arthritis Rheumatol. 2021;73(Suppl 9)

    Source: medipol.com.tr profile page

  13. 12. Toz B, et al., Oğuz E. IL-1 inhibitors in FMF-associated amyloidosis: Retrospective analysis. Arthritis Rheumatol. 2016;68(Suppl 10

    Source: medipol.com.tr profile page